Teva Pharma Industries Stock Market Value
| TEVA Stock | USD 16.59 0.10 0.60% |
| Symbol | Teva |
Teva Pharma Industries Price To Book Ratio
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Teva Pharma. If investors know Teva will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Teva Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.4 | Earnings Share (0.85) | Revenue Per Share 14.879 | Quarterly Revenue Growth 0.125 | Return On Assets 0.0556 |
The market value of Teva Pharma Industries is measured differently than its book value, which is the value of Teva that is recorded on the company's balance sheet. Investors also form their own opinion of Teva Pharma's value that differs from its market value or its book value, called intrinsic value, which is Teva Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Teva Pharma's market value can be influenced by many factors that don't directly affect Teva Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Teva Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Teva Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Teva Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Teva Pharma 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Teva Pharma's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Teva Pharma.
| 10/27/2024 |
| 11/26/2024 |
If you would invest 0.00 in Teva Pharma on October 27, 2024 and sell it all today you would earn a total of 0.00 from holding Teva Pharma Industries or generate 0.0% return on investment in Teva Pharma over 30 days. Teva Pharma is related to or competes with Haleon Plc, Bausch Health, Zoetis, Takeda Pharmaceutical, Elanco Animal, Viatris, and Catalent. Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes gener... More
Teva Pharma Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Teva Pharma's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Teva Pharma Industries upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.15) | |||
| Maximum Drawdown | 12.42 | |||
| Value At Risk | (2.23) | |||
| Potential Upside | 2.51 |
Teva Pharma Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Teva Pharma's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Teva Pharma's standard deviation. In reality, there are many statistical measures that can use Teva Pharma historical prices to predict the future Teva Pharma's volatility.| Risk Adjusted Performance | (0.06) | |||
| Jensen Alpha | (0.11) | |||
| Total Risk Alpha | (0.43) | |||
| Treynor Ratio | 0.4344 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Teva Pharma's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Teva Pharma Industries Backtested Returns
Teva Pharma Industries owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.0837, which indicates the firm had a -0.0837% return per unit of risk over the last 3 months. Teva Pharma Industries exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Teva Pharma's Risk Adjusted Performance of (0.06), variance of 3.14, and Coefficient Of Variation of (1,221) to confirm the risk estimate we provide. The entity has a beta of -0.36, which indicates possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Teva Pharma are expected to decrease at a much lower rate. During the bear market, Teva Pharma is likely to outperform the market. At this point, Teva Pharma Industries has a negative expected return of -0.15%. Please make sure to validate Teva Pharma's potential upside, daily balance of power, as well as the relationship between the Daily Balance Of Power and price action indicator , to decide if Teva Pharma Industries performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.31 |
Poor reverse predictability
Teva Pharma Industries has poor reverse predictability. Overlapping area represents the amount of predictability between Teva Pharma time series from 27th of October 2024 to 11th of November 2024 and 11th of November 2024 to 26th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Teva Pharma Industries price movement. The serial correlation of -0.31 indicates that nearly 31.0% of current Teva Pharma price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.31 | |
| Spearman Rank Test | 0.06 | |
| Residual Average | 0.0 | |
| Price Variance | 0.08 |
Teva Pharma Industries lagged returns against current returns
Autocorrelation, which is Teva Pharma stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Teva Pharma's stock expected returns. We can calculate the autocorrelation of Teva Pharma returns to help us make a trade decision. For example, suppose you find that Teva Pharma has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Teva Pharma regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Teva Pharma stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Teva Pharma stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Teva Pharma stock over time.
Current vs Lagged Prices |
| Timeline |
Teva Pharma Lagged Returns
When evaluating Teva Pharma's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Teva Pharma stock have on its future price. Teva Pharma autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Teva Pharma autocorrelation shows the relationship between Teva Pharma stock current value and its past values and can show if there is a momentum factor associated with investing in Teva Pharma Industries.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Teva Pharma Industries offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Teva Pharma's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Teva Pharma Industries Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Teva Pharma Industries Stock:Check out Teva Pharma Correlation, Teva Pharma Volatility and Teva Pharma Alpha and Beta module to complement your research on Teva Pharma. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Teva Pharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.